Chugai Pharmaceutical Co Ltd CHGCY:Grey Market

*Data is delayed | Exchange | USD
Last | 03/28/24 EDT
19.13quote price arrow down-0.43 (-2.17%)
Volume
38,068
52 week range
11.93 - 22.61
Loading...
  • Open18.45
  • Day High19.65
  • Day Low18.45
  • Prev Close19.55
  • 52 Week High22.61
  • 52 Week High Date03/11/24
  • 52 Week Low11.93
  • 52 Week Low Date04/20/23

Key Stats

  • Market Cap63,958.96M
  • Shares Out1,645.31M
  • 10 Day Average Volume110,321.1
  • Dividend0.29
  • Dividend Yield1.50%
  • Beta-
  • YTD % Change1.49

KEY STATS

  • Open18.45
  • Day High19.65
  • Day Low18.45
  • Prev Close19.55
  • 52 Week High22.61
  • 52 Week High Date03/11/24
  • 52 Week Low11.93
  • 52 Week Low Date04/20/23
  • Market Cap63,958.96M
  • Shares Out1,645.31M
  • 10 Day Average Volume110,321.1
  • Dividend0.29
  • Dividend Yield1.50%
  • Beta-
  • YTD % Change1.49

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Chugai Pharmaceutical Co Ltd

 

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
CHUGAI PHARMACEUTICAL CO., LTD. is a Japan-based company mainly engaged in the research, development, manufacture, sale, import and export of pharmaceutical products. The pharmaceutical products and medical devices for patients include ACTEMRA, Avastin, ALAGLIO, Aresensa, Kadosaira, Gazaiba, Seruseputo, Zeruborafu, Zeroda, Taruseba, Tecentoriku, Pajeta and other products. The products are mainly applied to the treatment of cancer, kidney diseases, kidney transplantation, bone...
Osamu Okuda
President, Chief Executive Officer, Representative Director
Toshiaki Itagaki
Chief Financial Officer, Senior Executive Officer, Director
Address
15F, Nihonbashi Mitsui Tower
2-1-1, Nihonbashi-Muro-machi
Chuo-ku, TKY
103-8324
Japan